Spectrum of Congenital Anomalies in Myhre Syndrome—Insights Into Effects Brought by Altered TGF ‐β Signaling via Gain‐of‐Function Variants in SMAD4
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2025
DOI: 10.1002/ajmg.c.70007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2025. Verfasst von Kawmadi Gunawardena und 13 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Hauptthemen laut MEDLINE: Smad4 Protein, Hand Deformities, Congenital, Intellectual Disability, Cryptorchidism. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myhre syndrome is a rare genetic disorder characterized by progressive multisystem involvement. Gain‐of‐function missense heterozygous variants affecting the Ile500 residue and Arg496 residue of the SMAD4 gene are implicated in this condition. In this article, we aim to understand the spectrum of congenital anomalies in Myhre syndrome by studying a cohort of previously unreported patients alongside published literature. Our analysis revealed that the musculoskeletal system was the most common system to be affected, followed by the cardiovascular system. Intrauterine growth restriction was the most reported intrauterine anomaly. Although there was no clear genotype–phenotype correlation, it appears that the Ile500Thr variant showed early multisystem involvement compared to other variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
- Genomics and Experimental Medicine Program, Scuola Superiore Meridionale (SSM, School of Advanced Studies), Naples, Italy.
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
- Clinical Genetics Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
- SW Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, UK.
ORCID-Profile: Kawmadi Gunawardena, Alessandro De Falco, Erina Sasaki, Shane McKee, Nicola Brunetti-Pierri
Zitieren
APA
Gunawardena, K., De Falco, A., Osio, D., Sherlock, E., Kivuva, E., Sasaki, E., Sansbury, F. H., Lahiri, N., Foley, P., Mansour, S., McKee, S., Ashraf, T., Brunetti-Pierri, N., & Kini, U. (2025). Spectrum of Congenital Anomalies in Myhre Syndrome—Insights Into Effects Brought by Altered TGF ‐β Signaling via Gain‐of‐Function Variants in SMAD4. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.70007
Vancouver
Gunawardena K, De Falco A, Osio D, Sherlock E, Kivuva E, Sasaki E, et al. Spectrum of Congenital Anomalies in Myhre Syndrome—Insights Into Effects Brought by Altered TGF ‐β Signaling via Gain‐of‐Function Variants in SMAD4. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2025. doi:10.1002/ajmg.c.70007
BibTeX
@article{Gunawardena2025,
author = {Gunawardena, Kawmadi and De Falco, Alessandro and Osio, Deborah and Sherlock, Eleanor and Kivuva, Emma and Sasaki, Erina and Sansbury, Francis H and Lahiri, Nayana and Foley, Patricia and Mansour, Sahar and McKee, Shane and Ashraf, Tazeen and Brunetti-Pierri, Nicola and Kini, Usha},
title = {Spectrum of Congenital Anomalies in Myhre Syndrome—Insights Into Effects Brought by Altered TGF ‐β Signaling via Gain‐of‐Function Variants in SMAD4},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2025},
doi = {10.1002/ajmg.c.70007}
}
EUVIMED